Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Antiemetic Therapy with Intramuscular Levonantradol vs Oral Tetrahydrocannabinol for Patients Receiving Antineoplastic Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
UMCC-8135
2.
Phase II-III Antiemetic Therapy with Levonantradol for Patients Receiving Cancer Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
18 to 70
UMCC-8027
3.
Antiemetic Therapy with Levonantradol vs Prochlorperazine for Cancer Patients Receiving Nausea-Inducing Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
16 to 80
WCCC-CO-8096
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute